Home » Stocks » ResMed

ResMed Inc. (RMD)

Stock Price: $202.51 USD -1.95 (-0.95%)
Updated Jul 31, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 29.30B
Revenue (ttm) 2.89B
Net Income (ttm) 512.64M
Shares Out 144.67M
EPS (ttm) 3.52
PE Ratio 57.53
Forward PE 44.44
Dividend $1.56
Dividend Yield 0.77%

Stock Quote

Trading Day Jul 31, 2020
Last Price $202.51
Previous Close $204.46
Change ($) -1.95
Change (%) -0.95%
Day's Open 205.53
Day's Range 200.81 - 206.17
Day's Volume 537,502
52-Week Range 108.85 - 209.00

More Stats

Market Cap 29.30B
Enterprise Value 30.45B
Earnings Date (est) Aug 5, 2020
Ex-Dividend Date May 13, 2020
Shares Outstanding 144.67M
Float 143.38M
EPS (basic) 3.56
EPS (diluted) 3.52
FCF / Share 3.56
Dividend $1.56
Dividend Yield 0.77%
Earnings Yield 1.74%
FCF Yield 1.76%
Payout Ratio 43.30%
Shares Short 1.76M
Short Ratio 2.44
Short % of Float 1.37%
Beta 0.51
PE Ratio 57.53
Forward PE 44.44
P/FCF Ratio 56.97
PS Ratio 10.13
PB Ratio 13.18
Revenue 2.89B
Operating Income 707.49M
Net Income 512.64M
Free Cash Flow 514.25M
Net Cash -1.15B
Net Cash / Share -7.98
Gross Margin 53.14%
Operating Margin 24.47%
Profit Margin 17.70%
FCF Margin 17.78%
ROA 11.00%
ROE 23.97%
ROIC 26.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (18)

Buy 7
Overweight 1
Hold 5
Underweight 0
Sell 5

Analyst Consensus: Overweight

Price Target

$174.19*
(-13.98% downside)
Low
135
Current: $202.51
High
206
Target: 174.19
*Average 12-month price target from 13 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue2,6072,3402,0671,8391,6791,5551,5141,3691,2431,092
Revenue Growth11.38%13.23%12.4%9.52%7.97%2.68%10.66%10.08%13.8%-
Gross Profit1,5371,3621,2021,0661,011990941821741655
Operating Income579542426429409405355294267240
Net Income405316342352353345307255227190
Shares Outstanding143143141140140141143146152151
Earnings Per Share2.802.192.402.492.472.392.101.711.441.23
EPS Growth27.85%-8.75%-3.61%0.81%3.35%13.81%22.81%18.75%17.07%-
Dividend Per Share1.481.401.321.201.121.000.68---
Dividend Growth5.71%6.06%10%7.14%12%47.06%----
Operating Cash Flow459505414548383391403383283188
Capital Expenditures-68.71-62.58-62.22-58.53-62.50-72.72-63.58-47.14-66.61-56.86
Free Cash Flow390442352489321319339336217131
Cash & Equivalents147189822731717906876810735489
Total Debt1,2712811,0791,173301301301251100122
Net Cash / Debt-1,124-92.75-257-441417605575559635367
Assets4,1083,0643,4683,2572,1822,3612,2112,1382,0691,626
Liabilities2,0351,0051,5081,562594603600530338339
Book Value2,0722,0591,9601,6951,5871,7581,6111,6081,7311,288
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name ResMed Inc.
Country United States
Employees 7,240
CEO Michael J. Farrell

Stock Information

Ticker Symbol RMD
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NYSE: RMD
IPO Date June 2, 1995

Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software solutions that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates through two segments, Sleep and Respiratory Care, and Software as a Service (SaaS). It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; data communications and control products, such as AirView Diagnostics, EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules; U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as S+, connectivity module, and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and healthcare-first and matrixcare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.